Interestingly, in vivo the treatment with ICOVIR15-TKT +GCV produces a major antitumoral effect, probably because GCV toxic metabolites can spread to non-infected neighbouring tumoral or stromal cells increasing tumor cell destruction [19, 20]. This evidence concerns the gene TKT and neoplasm.